Ontario Genomics invests in renewable chemicals – Ontario Genomics Ontario Genomics is pleased to announce its investment in Ardra Inc. via its Pre-Commercial Business Development Fund. Ardra is a specialty chemicals company focused on the production of natural ingredients for the cosmetics and flavour and fragrance industries. Their synthetic biology platform uses designer biochemical pathways… Read more »
Posts Categorized: Uncategorized
Artificial intelligence takes the drudgery out of legal work For years, budding airplane pilots and race-car drivers have been able to strap themselves into virtual simulators to test their respective skills and odds of real-world success. But what about lawyers? Recent advances in artificial intelligence and machine learning mean legal professionals are now getting the… Read more »
One of the biggest challenges Albert Tai faced when launching a startup was finding the space to do it. The co-founder of Hypercare, a UTEST company from the 2015 cohort, a communication and collaboration app for doctors, recalls bouncing from classroom to coffee shop at the University of Toronto as he and his team looked for places to… Read more »
Deep Genomics, part of the 2015 UTEST cohort, has raised US$13 million from Khosla Ventures. Deep Genomics combines artificial intelligence and genomics research to help develop genetic medicines to treat a myriad of disorders – everything from autism to cancer. Brendan Frey, CEO and a professor in U of T’s Faculty of Applied Science & Engineering, told the Globe… Read more »
Congratulations to Dalriada Therapeutics for winning the inaugural RBC Innovation & Entrepreneurship Prize! CEO Diana Kraskouskaya did a tremendous job telling the Dalriada story and walked away with $25K in prize money. Full event details found here Pictured above: Professor Cynthia Goh, Gabriel Woo, RBC’s vice-president of innovation, Dalriada CEO, Diana Kraskouskaya and CSO, Professor Patrick Gunning.
UT Entrepreneurship announced their top 6 finalists for the RBC Prize for Innovation. UTEST will be represented by: Dalriada Therapeutics is developing a unique ‘cloaking’ therapeutic technology for the treatment of most aggressive, currently untreatable cancers including acute myeloid leukaemia, glioblastoma and medulloblastoma. Dash MD is a mobile patient experience platform that improves recovery outcomes by… Read more »
UTEST applications for the 2018/2019 cohort will be opening shortly. If you have questions regarding our next application intake please email Kurtis – email@example.com
Powered by Eventbrite
Introducing the Ignite Top 27 Finalists! The first round of Ignite pitches are complete and we have our Top 27! Ignite saw 67 incredible innovation, technology or invention based businesses apply. This week, Ignite held three separate competitions for the three categories; Student Entrepreneur, Young Entrepreneur and General Entrepreneur.